Zobrazeno 1 - 10
of 174
pro vyhledávání: '"An S De Vriese"'
Autor:
Sofie A.M. Dhaese, An S. De Vriese
Publikováno v:
Mayo Clinic Proceedings. 98:750-770
Publikováno v:
The Lancet. 399:1646-1663
Glomerulonephritis is a heterogeneous group of disorders that present with a combination of haematuria, proteinuria, hypertension, and reduction in kidney function to a variable degree. Acute presentation with full blown nephritic syndrome or rapidly
Publikováno v:
Artery Research, Vol 20 (2017)
Background: Individualized weighing of the risk-benefit of anticoagulation is recommended in patients with atrial fibrillation (AF) that have low established risk scores or, conversely, are at increased risk for bleeding1. Parameters of arterial stif
Externí odkaz:
https://doaj.org/article/a8e1b0921bb74b619607442b0af36511
Publikováno v:
J Am Soc Nephrol
Background In patients with normal renal function or early stage CKD, the risk-benefit profile of direct oral anticoagulants (DOACs) is superior to that of vitamin K antagonists (VKAs). In patients on hemodialysis, the comparative efficacy and safety
Autor:
Jens T Van Praet, Marie De Groote, Dirk De Bacquer, Ellen Verhalleman, Ziggy Welvaert, Jan Emmerechts, Marijke Reynders, An S De Vriese
Publikováno v:
OPEN FORUM INFECTIOUS DISEASES
Background Chronic kidney disease is associated with increased risk of frailty and accelerated immune senescence, potentially affecting the immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination. Methods Humoral a
Autor:
Casal Moura Marta, Sanjeev Sethi, Julie A. Vrana, Samar M. Said, John C. Lieske, Shane A. Bobart, An S. De Vriese, Samih H. Nasr, Mariam P. Alexander, Callen D. Giesen, Fernando C. Fervenza, Shahrzad Tehranian
Publikováno v:
Mayo Clinic Proceedings. 96:577-591
Objective To describe the clinical and pathological phenotype of membranous nephropathy (MN) associated with M-type-phospholipase–A2-receptor (PLA2R), thrombospondin-type-1-domain-containing-7A (THSD7A), semaphorin 3B (SEMA3B), neural-epidermal-gro
Autor:
An S De Vriese, Annick D’Haeninck, Artur Mendes, Augusto Ministro, Dainis Krievins, David Kingsmore, Gaspar Mestres, Gonzalo Villanueva, Hugo Rodrigues, Jakub Turek, Maciej Zieliński, Jan De Letter, Andreia Coelho, Luís Alvarenga Loureiro, Matteo Tozzi, Mirko Menegolo, Palma Fariñas Alija, Panagiotis G Theodoridis, Paul Gibbs, Reze Ebrahimi, Sigi Nauwelaers, Stavros K Kakkos, Vladimir Matoussevitch, Frans Moll, Mauro Gargiulo
Publikováno v:
The Journal of Vascular Access. :112972982311749
Background: Arteriovenous grafts (AVGs) are used for patients deemed unsuitable for the creation of an autogenous arteriovenous fistula (AVF) or unable to await maturation of the AVF before starting hemodialysis. However, AVGs are prone to infection
Autor:
Deborah Steensels, Liesbeth Viaene, An S. De Vriese, Peter Doubel, Jens Van Praet, Melanie Schoutteten, Line Heylen, Bruno Van Vlem, Rogier Caluwé, Annelies De Bel, Dirk De Bacquer, Marijke Reynders
Publikováno v:
J Am Soc Nephrol
BACKGROUND: Preliminary evidence suggests patients on hemodialysis have a blunted early serological response to SARS-CoV-2 vaccination. Optimizing the vaccination strategy in this population requires a thorough understanding of predictors and dynamic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa510d5356d1e7f88ad1b452069a8394
https://europepmc.org/articles/PMC8638385/
https://europepmc.org/articles/PMC8638385/
Autor:
Shahrzad Tehranian, Callen D. Giesen, Shane A. Bobart, Heedeok Han, Juan Carlos León Román, Sanjeev Sethi, Ladan Zand, Cristina Andrades Gomez, An S. De Vriese, María José Soler, Andrew S. Bomback, Fernando C. Fervenza
Publikováno v:
Clin J Am Soc Nephrol
Background and objectives Kidney biopsy is the current gold standard to diagnose membranous nephropathy. Approximately 70%–80% of patients with primary membranous nephropathy have circulating anti-phospholipase A2 receptor antibodies. We previously
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8377b78d076f26bbf35ce5eccd4aa322
https://europepmc.org/articles/PMC8729491/
https://europepmc.org/articles/PMC8729491/
Publikováno v:
Clinical Infectious Diseases. 73:2145-2147